These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 30942450)
1. Upregulation of microRNA‑16 alters the response to inhaled β‑agonists in patients with asthma though modulating expression of ADRB2. Yu B; Yao L; Liu C; Tang L; Xing T Mol Med Rep; 2019 May; 19(5):4027-4034. PubMed ID: 30942450 [TBL] [Abstract][Full Text] [Related]
2. Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response. Ambrose HJ; Lawrance RM; Cresswell CJ; Goldman M; Meyers DA; Bleecker ER Respir Res; 2012 May; 13(1):37. PubMed ID: 22559839 [TBL] [Abstract][Full Text] [Related]
3. [GENETIC INTERACTIONS BETWEEN ADRB2 AND PTGER4 ON RESPONSES TO SALMETEROL OR MONTELUKAST IN JAPANESE PATIENTS WITH MILD PERSISTENT ASTHMA]. Yamada H; Masuko H; Inui T; Kanazawa J; Yatagai Y; Sakamoto T; Iijima H; Konno S; Shimizu K; Makita H; Nishimura M; Kokubu F; Saito T; Endo T; Ninomiya H; Kaneko N; Hizawa N Arerugi; 2016; 65(9):1201-1208. PubMed ID: 27885204 [TBL] [Abstract][Full Text] [Related]
4. Effects of formoterol or salmeterol on impulse oscillometry in patients with persistent asthma. Manoharan A; von Wilamowitz-Moellendorff A; Morrison A; Lipworth BJ J Allergy Clin Immunol; 2016 Mar; 137(3):727-33.e1. PubMed ID: 26220533 [TBL] [Abstract][Full Text] [Related]
5. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033 [TBL] [Abstract][Full Text] [Related]
6. Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes. Panebra A; Wang WC; Malone MM; Pitter DR; Weiss ST; Hawkins GA; Liggett SB PLoS One; 2010 Jul; 5(7):e11819. PubMed ID: 20686604 [TBL] [Abstract][Full Text] [Related]
7. Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. Basu K; Palmer CN; Tavendale R; Lipworth BJ; Mukhopadhyay S J Allergy Clin Immunol; 2009 Dec; 124(6):1188-94.e3. PubMed ID: 19800676 [TBL] [Abstract][Full Text] [Related]
8. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response. Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children. Elbehidy RM; Youssef DM; El-Shal AS; Shalaby SM; Sherbiny HS; Sherief LM; Akeel NE Mol Immunol; 2016 Mar; 71():107-114. PubMed ID: 26874829 [TBL] [Abstract][Full Text] [Related]
10. A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β Kim D; Cho S; Woo JA; Liggett SB FASEB J; 2018 Jul; 32(7):3680-3688. PubMed ID: 29455573 [TBL] [Abstract][Full Text] [Related]
11. Reduced suppressive effect of β Lo CY; Michaeloudes C; Bhavsar PK; Huang CD; Chang PJ; Wang CH; Kuo HP; Chung KF Respir Res; 2017 Nov; 18(1):194. PubMed ID: 29162108 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4. Liang X; Xu Z; Yuan M; Zhang Y; Zhao B; Wang J; Zhang A; Li G Int J Mol Med; 2016 Apr; 37(4):967-75. PubMed ID: 26936421 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑16 inhibits interleukin‑13‑induced inflammatory cytokine secretion and mucus production in nasal epithelial cells by suppressing the IκB kinase β/nuclear factor‑κB pathway. Gao Y; Yu Z Mol Med Rep; 2018 Oct; 18(4):4042-4050. PubMed ID: 30132525 [TBL] [Abstract][Full Text] [Related]
14. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy. Kim SH; Ye YM; Lee HY; Sin HJ; Park HS J Clin Pharm Ther; 2011 Jun; 36(3):399-405. PubMed ID: 21545619 [TBL] [Abstract][Full Text] [Related]
15. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
17. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L Respiration; 2001; 68(5):452-9. PubMed ID: 11694805 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma. Mendes ES; Rebolledo P; Wanner A Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058 [TBL] [Abstract][Full Text] [Related]
20. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma. Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]